2018 International Congress Archives - Page 23 of 177

1:45pm-3:15pm: Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease

C. Kutz, L. Adams, E. Moncheski (Colorado Springs, CO, USA)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: Effects of Expiratory Muscle Strength Training and Voice Therapy on Parkinsonian Speech

T.S. Tong, M.W. Ng (Pokfulam, Hong Kong)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) Combined with Task Specific Training in Individuals with Parkinson’s Disease

J. Thanakamchokchai, J. Tretriluxana, B. Fisher, N. Pakaprot, A. PisarnPong (Nakhon Pathom, Thailand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of Intensive Voice and Articulation Treatments on Voice Quality in Parkinson’s disease

J. Spielman, L. Ramig, K. Freeman, A. Halpern, Y. Maryn (Denver, CO, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of JN403, an α-7-nicotine-acetylcholine-receptor (α7-nAChR) agonist on human alpha-synuclein-mediated in vitro and in vivo models of Parkinson’s disease

B. Lee, C. Noelker, W. Chiu, D. Feuerbach, L. Timmerman, W. Oertel (Marburg, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of Korean Medicine on Postural Instability and Gait Difficulty in Patient with Parkinsonism

HM. Lee, SB. Yang, SY. Cho, JM. Park, CN. Ko, SU. Park (Seoul, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of Long-Term Valbenazine on Tardive Dyskinesia by Body Region: Shift Analyses of KINECT 4 Study Results

C. Comella, C. Singer, S. Marder, J. Burke, K. Farahmand, R. Jimenez, S. Siegert (Chicago, IL, USA)

Drug-Induced Movement Disorders · Hall 3FG

1:45pm-3:15pm: Effects of MRI-guided Focused Ultrasound unilateral subthalamotomy on characteristics of EMG activity underlying reaction time and tapping test in Parkinson’s disease

D. Urso, B. Fernández-Rodríguez, R. Rodríguez-Rojas, M. del Álamo, F. Hernández-Fernández, J. Pineda-Pardo, M. Dileone, G. Foffani, I. Obeso, C. Gasca-Salas, L. Vela, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Móstoles, Spain)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Effects of non-invasive brain stimulation on motor-speech disorders in Parkinson’s disease

I. Rektorova, P. Klobusiakova, L. Brabenec, J. Mekyska, Z. Galaz, M. Kostalova (Brno, Czech Republic)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of PGE inhibition on Striatal Neuroinflammation in 6-OHDA lesion

T. Adu, M. Mabandla (Durban, South Africa)

Drug-Induced Movement Disorders · Hall 3FG